The decision comes a few months after the first drug to be approved in the UK for alopecia – Eli Lilly ... and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.

A man suffering alopecia says he is being denied a groundbreaking new drug – despite it being approved. The daily pill, called ritlecitinib or Litfulo, was green-lit for prescription on the NHS ...

"Our findings underscore that LDOM remains effective in treating alopecia, even in medically complex patients with multi-drug regimens involving ... of Medicine in New York City, and colleagues.

Lilly and Incyte's already-marketed JAK inhibitor Olumiant (baricitinib) is currently in the lead among drugs for alopecia areata ... slowing down approvals of new indications across the class.

Shares of Q32 Bio were touching all-time lows in the after-hours market following results from a pair of Phase 2a clinical trials of the company's alopecia treatment bempikibart. The company said ...

A woman with alopecia has welcomed approval for a new hair loss medicine on the NHS ... The daily pill has been approved by drug body NICE for hair loss caused by autoimmune disease.

Sporting a white dress and a red headscarf, Japan’s version of a Barbie doll has a new look to battle the ... when the company developed a curative drug for alopecia areata, Nishimura has ...